ArticleBlood advances2019

Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.

Qiu-Sha Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.